PatentVest, a unit of MDB Capital, completed a strategic intellectual property collaboration with Porosome Therapeutics. The work covered an IP portfolio audit and global patent landscape analysis. It also included competitive benchmarking and a strategic partner assessment.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MDB Capital Holdings LLC published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603111222PRIMZONEFULLFEED9670191) on March 11, 2026, and is solely responsible for the information contained therein.